Potassium channel activators: pharmacological methods, models, and structure-activity relationships.
SmithKline Beecham Pharmaceuticals, Pinnacles, Harlow, Essex, U.K.
J M
JM
Evans
S G
SG
Taylor
D000818:Animals; D000959:Antihypertensive Agents / Q000737:chemistry / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008954:Models, Biological; D015221:Potassium Channels / Q000187:drug effects*; D013329:Structure-Activity Relationship
D000959:Antihypertensive Agents; D015221:Potassium Channels